Christophe Bourdon
Director/Board Member chez SWEDISH ORPHAN BIOVITRUM AB
Profil
Christophe Bourdon is currently a Director at Swedish Orphan Biovitrum AB.
Previously, he served as the Chief Executive Officer at Orphazyme A from 2021 to 2022.
He also held the position of Senior Vice President & General Manager-US Oncology at Amgen, Inc. Mr. Bourdon holds an MBA from the International Institute for Management Development and an undergraduate degree from Institut Supérieur de Gestion.
Postes actifs de Christophe Bourdon
| Sociétés | Poste | Début |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 01/01/2023 |
Anciens postes connus de Christophe Bourdon
| Sociétés | Poste | Fin |
|---|---|---|
| ORPHAZYME A/S | Chief Executive Officer | 01/04/2022 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Christophe Bourdon
| International Institute for Management Development | Masters Business Admin |
| Institut Supérieur de Gestion | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
